Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
53.9M
Number of holders
52
Total 13F shares, excl. options
19.2M
Shares change
-61.5K
Total reported value, excl. options
$76.8M
Value change
-$539K
Number of buys
29
Number of sells
-10
Price
$4.00

Significant Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q4 2024

55 filings reported holding OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19.2M shares of 53.9M outstanding shares and own 35.6% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (8.21M shares), PERCEPTIVE ADVISORS LLC (4.59M shares), BlackRock, Inc. (1.98M shares), VANGUARD GROUP INC (1.32M shares), GEODE CAPITAL MANAGEMENT, LLC (572K shares), PRICE T ROWE ASSOCIATES INC /MD/ (487K shares), STATE STREET CORP (448K shares), Boxer Capital Management, LLC (238K shares), NORTHERN TRUST CORP (237K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (219K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.